CoChat

Adjuvant Tamoxifen Prescription in Women 65 Years and Older With Primary Breast Cancer

Silliman, Rebecca A., Guadagnoli, Edward, Rakowski, William, Landrum, Mary Beth, Lash, Timothy L., Wolf, Robert, Fink, Aliza, Ganz, Patricia A., Gurwitz, Jerry, Borbas, Catherine, Mor, Vincent · 2002 · Journal of Clinical Oncology
Cited by 92

The DOI matches its Crossref record.

Abstract

PURPOSE: We examined patterns of adjuvant tamoxifen discussion and prescription among breast cancer patients age 65 years and older. METHODS: We selected from women diagnosed with primary breast cancer those with (1) stage I (tumor diameter ≥ 1 cm), stage II, or stage IIIa disease; (2) age 65 years or older on the date of diagnosis; and (3) permission from the attending physician to contact. Data were collected from consenting patients’ medical records, telephone interviews with patients, and mailed questionnaires completed by their physicians. RESULTS: We obtained medical record and interview data for 698 patients. The oldest patients (odds ratio [OR], 0.45; 95% confidence interval [CI], 0.23 to 0.87 for those aged 80+ relative to those aged 65 to 69 years old), those with more comorbid conditions (each additional comorbid condition reduced the odds of discussion by 0.84; 95% CI, 0.73 to 0.96), and those who were estrogen receptor–negative (OR, 0.56; 95% CI, 0.32 to 0.99) were less likely to report discussion of tamoxifen therapy with a physician. Older patients (OR, 2.17; 95% CI, 1.18 to 4.01 for 70- to 79-year-olds relative to 65- to 69-year-olds; OR, 2.44; 95% CI, 1.11 to 5.34 for those aged 80+ relative to those aged 65 to 69 years old), those who reported a greater influence of information about tamoxifen on decision-making (an increase in 1 SD increased the odds by 7.43; 95% CI, 4.36 to 12.65), and those whose physicians believed that the benefits of tamoxifen outweighed its risks (an increase in 1 SD increased the odds by 1.87; 95% CI, 1.34 to 2.62) were more likely to be prescribed tamoxifen. CONCLUSION: These findings highlight the key role of communication in the care of older women with breast cancer and its ultimate influence on the receipt of therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2002.08.137

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 92

Metadata

Authors
Silliman, R. A., Guadagnoli, E., Rakowski, W., Landrum, M. B., Lash, T. L., Wolf, R., Fink, A., Ganz, P. A., Gurwitz, J., Borbas, C., & Mor, V.
Venue
Journal of Clinical Oncology
Published
2002-06-01
Volume
20
Issue
11
Pages
2680-2688
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2140016894
Cited by
92
References
0
FWCI
11.22
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adjuvant Tamoxifen Prescription in Women 65 Years and Older With Primary Breast Cancer. https://app.cochat.ai/papers/10.1200/jco.2002.08.137
The paper
Silliman, R. A., Guadagnoli, E., Rakowski, W., Landrum, M. B., Lash, T. L., Wolf, R., Fink, A., Ganz, P. A., Gurwitz, J., Borbas, C., & Mor, V. (2002). Adjuvant Tamoxifen Prescription in Women 65 Years and Older With Primary Breast Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2002.08.137

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.